Emmet Keating

Emmet Keating
T: +44 (0) 121 654 5021
E: emmet.keating@alantra.com

Emmet is a Director at Alantra with over ten years M&A experience.

He is one of the most experienced deal executors in our UK Advisory team, having worked with each of the UK-based partners.

Recent transactions include the management buy-out of Acton Banks; the refinancing of Inspired Thinking Group (ITG); advising GI Solutions Group on the acquisition of the Eclipse Group; the growth capital investment in Exclaimer; and the sales of Adapt to US-based Datapipe, Fleet Hire to Australia-based SG Fleet Group, Texon to South-East Asia-based Navis Capital Partners, Bluefin Solutions to India-based Mindtree, Shimtech Industries to Auctus Industries, Williams Medical Supplies to DCC plc, and Rhead Group to Costain PLC.

Emmet works closely with Richard Sanders, both in the TMT sector and West Midlands regional market, advising business owners and management teams on private equity, growth capital and trade sale transactions.

A graduate of Manchester University, Emmet qualified as a chartered accountant with Deloitte in their TMT sector team.

Emmet says he enjoys watching football, although as a Coventry fan, this is difficult to believe. Married with three young children, he will probably pass this affliction onto them.

 

Alantra appoints experienced partner to head up its UK Real Estate & Hospitality team

Alantra has appointed Hoong Wey Woon as a Partner to head up its UK Real Estate & Hospitality team.  

Alantra advises Strong Roots on securing over €15.5m of investment

Alantra advises Strong Roots, one of the UK’s fastest-growing food companies, on securing over €15.5m of investment 

Alantra advises i2S on its sale to Gfi Informatique

Alantra advises Portuguese IT firm, i2S, on its sale to Gfi Informatique 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.